News

Notable healthcare headlines for the week: Gilead, CVS Health, Sanofi in focus
Merck KGaA to buy Springworks for $3.9 billion Merck KGaA (OTCPK:MKGAF) is set to acquire SpringWorks Therapeutics (SWTX) for ...
GEN - Genetic Engineering and Biotechnology News1h
Recursion Halts Four Pipeline Programs, Sharpening Cancer, Rare Disease Focus
Recursion said it earned its latest milestone payout by identifying differentiated, oral small molecule leads against a target the company described as a high interest immune cell target in immunology ...